Ignite Creation Date:
2024-05-05 @ 11:00 PM
Last Modification Date:
2024-10-26 @ 10:27 AM
Study NCT ID:
NCT01231022
Status:
COMPLETED
Last Update Posted:
2015-07-29
First Post:
2010-10-20
Brief Title:
Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer MBC
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Study Overview
Official Title:
Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MBC
Brief Summary:
The investigators want to know the role of Peripheral hematopoietic stem cell infusion in avoiding Drug Induced Liver Injuryand also try to research SNPs genotyping associated with Drug Induced Liver Injury
Detailed Description:
1 The researcher investigate the incidence and the cause of Drug Induced Liver Injury in MBC
2 Patients having a complete clinical history and physical examination receive routine chemotherapy
3 Venous blood Sample4 mlis collected before and after each cycle according to the planning time
4 Genomic DNARNA and upper serum is isolated ELISArt-PCR or PCR-direct sequencing is used to detect the protein or gene expression associated with liver function
2 Patients having a complete clinical history and physical examination receive routine chemotherapy
3 Venous blood Sample4 mlis collected before and after each cycle according to the planning time
4 Genomic DNARNA and upper serum is isolated ELISArt-PCR or PCR-direct sequencing is used to detect the protein or gene expression associated with liver function
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None